Hiv testing shortages in Morocco highlight gaps in national procurement

Morocco’s public health system has been grappling with a paradox: while domestic manufacturers produce certified HIV rapid tests ready for immediate delivery, national health facilities face chronic shortages lasting over a year. Patients in need of testing are often turned away, leaving communities vulnerable to undetected infections.

Systemic failures in public procurement

The root of this crisis lies in the country’s public procurement framework. Despite clear legal provisions mandating national preference in government contracts, bureaucratic inertia and restrictive technical specifications continue to favor foreign suppliers. Legal experts point to Decree No. 2.22.431, which explicitly prohibits procurement practices that exclude domestic producers through arbitrary technical requirements or brand-specific certifications.

Abdelhay Rhorba, a public procurement law specialist at Hassan II University of Casablanca, emphasizes that such practices constitute a violation of equal opportunity principles and may amount to abuse of power. “When technical criteria are drafted to favor a single foreign manufacturer, the exclusion of local producers becomes legally indefensible,” he explains. Moroccan administrative courts apply a straightforward test: if procurement documents—even if technically compliant—systematically sideline domestic industry, they can be challenged.

Legal recourse and administrative hurdles

While remedies exist—such as filing a complaint with the National Public Procurement Commission or pursuing litigation within 60 days—challenging entrenched procurement practices remains an uphill battle. The burden falls squarely on affected businesses, many of which lack the resources to contest government decisions. In cases involving suspected corruption, penalties under Morocco’s anti-bribery laws may also apply.

Technical barriers and market distortions

Field reports reveal that technical specifications for HIV test procurement are routinely drafted based on outdated foreign products rather than domestic alternatives. A confidential interview with a Moroccan medical device manufacturer highlights the absurdity: “Our company supplies certified HIV tests across Africa, yet we account for less than 2% of public sector purchases in Morocco.”

Efforts to clarify procurement motives often meet with silence. Despite government initiatives to raise tariffs on imported medical devices to support local industry, the Ministry of Health continues to purchase foreign-made tests at higher costs, ignoring competitively priced domestic equivalents. The contradiction extends to the highest levels of government, where conflicting policy signals undermine the push for self-sufficiency.

Sovereignty at risk: the cost of missed opportunities

The consequences extend beyond logistics. HIV rapid tests are critical for reaching marginalized populations that avoid traditional health facilities. Infectious disease expert Professor Jaafar Heikel underscores their role: “Organizations like OPALS and ALCS rely on these tests to screen populations that might never visit a lab.” Without consistent supply, Morocco’s ability to meet UNAIDS 95-95-95 targets—aiming to end AIDS as a public health threat by 2030—is at risk.

Local production not only ensures affordability but also strengthens national health security. “When the state validates domestically manufactured tests, it reduces costs and advances sovereignty,” Heikel asserts. Yet persistent procurement barriers stifle innovation and deter investment in Morocco’s health sector.

Transparency and accountability gaps

Publicly, the Ministry of Health denies bypassing procurement regulations, attributing shortages to global supply chain disruptions and administrative delays. However, critics question why domestic producers with available stock were not engaged during critical gaps. While the Ministry insists only competitive bidding was used, multiple sources contradict this claim, citing instances of sole-source contracts.

Under Moroccan law, sole-source procurement is permissible only under extreme urgency, technical exclusivity, or failed bidding—but requires written justification and proof of no alternatives. “Failure to comply turns these contracts into illegal practices,” Rhorba warns.

As frustration grows, voices within Morocco’s health sector question whether procurement commissions are prioritizing foreign suppliers over national interests. The message to innovators is clear: if domestic producers are systematically sidelined, investment in local manufacturing will dry up—leaving Morocco dependent on foreign suppliers for products it can produce itself.